Evidence map›Paper›PMID 18453575›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2008

Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation.

Nicolas Perez, Subha Karumuthil-Melethil, Ruobing Li, Bellur S Prabhakar, Mark J Holterman, Chenthamarakshan Vasu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nicolas PerezDepartment of Surgery, College of Medicine, University of Illinois, Chicago, IL 60612, USA.
Subha Karumuthil-Melethil
Ruobing Li
Bellur S Prabhakar
Mark J Holterman
Chenthamarakshan Vasu
Illinois College · USUniversity of Illinois Urbana-Champaign · US

Funding

Therapeutic treatment of EAT by inducing dendritic cellR01AI058190 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PRABHAKAR, BELLUR S · 2006 to 2010
$1.8M
Tissue Specific Therapy of Autoimmune Thyroid DiseaseK08AI001821 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HOLTERMAN, MARK J · 2002 to 2006
$607k
Microsphere based Tolerogenic antigen presentation systemR21AI069848 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI VASU, CHENTHAMARAKSHAN · 2006 to 2007
$420k
NIAID NIH HHS K08 AI 001821NIAID NIH HHS K08 AI001821NIAID NIH HHS R01 AI 058190NIAID NIH HHS R01 AI058190NIAID NIH HHS R21 AI 069848NIAID NIH HHS R21 AI069848
6 · The paper itself

Abstract

Costimulatory ligands CD80 and CD86 have different binding preferences and affinities to their receptors, CD28 and CTLA-4. Earlier, we demonstrated that CD80 binds to CTLA-4 with higher affinity and has a role in suppressing T cell response. The current study demonstrates that not only did blockade of CD86 upon Ag presentation by bone marrow-derived dendritic cells (DC) to OVA-specific T cells result in induction of hyporesponsive T cells but also that these T cells could suppress the proliferative response of effector T cells. These T cells showed TGF-beta1 on their surface and secreted TGF-beta1 and IL-10 upon restimulation. Although blockade of CTLA-4 and neutralization of IL-10 profoundly inhibited the induction of these TGF-beta1(+) T cells, their ability to suppress the effector T cell proliferation was abrogated by neutralization of TGF-beta1 alone. Induction of TGF-beta1(+) and IL-10(+) T cells was found to be independent of natural CD4(+)CD25(+) regulatory T cells, demonstrating that preferential ligation of CTLA-4 by CD80 induced IL-10 production by effector T cells, which in turn promoted the secretion of TGF-beta1. Treatment of prediabetic NOD mice with islet beta cell Ag-pulsed CD86(-/-) DCs, but not CD80(-/-) DCs, resulted in the induction of TGF-beta1- and IL-10-producing cells, significant suppression of insulitis, and delay of the onset of hyperglycemia. These observations demonstrate not only that CD80 preferentially binds to CTLA-4 but also that interaction during Ag presentation can result in IL-10-dependent TGF-beta1(+) regulatory T cell induction, reinstating the potential of approaches to preferentially engage CTLA-4 through CD80 during self-Ag presentation in suppressing autoimmunity.

Indexed as

AnimalsAntigen PresentationAntigens, CDB7-1 AntigenB7-2 AntigenCTLA-4 AntigenDendritic CellsDiabetes Mellitus, Type 1FemaleFlow CytometryInterleukin-10Lymphocyte ActivationMiceMice, Inbred NODT-Lymphocytes, RegulatoryT-Lymphocyte SubsetsAntigens, CDB7-1 AntigenB7-2 AntigenCTLA-4 AntigenCtla4 protein, mouseInterleukin-10Transforming Growth Factor beta

Identifiers

PMID18453575
PMCPMC2435403
OpenAlexW2027004619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.